0001161697-24-000062.txt : 20240206 0001161697-24-000062.hdr.sgml : 20240206 20240206170022 ACCESSION NUMBER: 0001161697-24-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240205 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DENKHAUS DONALD A CENTRAL INDEX KEY: 0001278439 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 24601043 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1500 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 02-05-2024 X0508 4 2024-02-05 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001278439 DENKHAUS DONALD A 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 1 0 0 0 0 Common Stock, par value $0.001 per share 2024-02-05 4 M 0 40000 4.01 A 434333 D Options to purchase common stock 4.01 2024-02-05 4 M 0 40000 0 D 2025-01-02 Common Stock 40000 192931 D Derivative securities vested in three equal tranches on January 2, 2019, 2020 and 2021. /s/ Donald A. Denkhaus 2024-02-06